Six-week sprint got Indian-made AstraZeneca vaccine approved in Canada
Problems at AstraZeneca Plc’s European production site in January kicked off a six-week push to get a version of its COVID-19 vaccine made at an Indian facility approved by Canada’s drug regulator, according to the Canadian pharmaceutical company that filed the application.
from bdnews24.com - Home https://ift.tt/3bVyzlM
from bdnews24.com - Home https://ift.tt/3bVyzlM
No comments